Morepen Clocks Highest-Ever Quarterly Revenue and Earnings in Q1'FY27; EBITDA Grows by 207% and PAT by 394%; CDMO Enters Full Scale Commercialization

Morepen Clocks Highest-Ever Quarterly Revenue and Earnings in Q1'FY27; EBITDA Grows by 207% and PAT by 394%; CDMO Enters Full Scale Commercialization

Release Date :
Produced By :
Directed By :
Cast :
Plot :

Morepen Clocks Highest-Ever Quarterly Revenue and Earnings in Q1'FY27; EBITDA Grows by 207% and PAT by 394%; CDMO Enters Full Scale Commercialization

Release Date :
Produced By :
Directed By :
Cast :
Plot :

Morepen Clocks Highest-Ever Quarterly Revenue and Earnings in Q1'FY27; EBITDA Grows by 207% and PAT by 394%; CDMO Enters Full Scale Commercialization

Release Date :
Produced By :
Directed By :
Cast :
Plot :

Similar Post